The Hong Kong Science and Technology Park aims to double the number of start-ups joining its upgraded incubation programme, with some companies saying the scheme will help to speed up the commercialisation of their products.
Advertisement
The park on Thursday launched its new life and health tech-focused incubation programme Incu-Bio, which is designed to offer start-ups support, such as assistance with laboratory research, regulatory activities and the advancement of research to a preclinical stage over a four-year period.
Derek Chim, the park’s head of start-up ecosystem and development, said that under the programme, enterprises would receive up to HK$6 million (US$771,000) each in the form of grants, subsidies and regulatory affairs funding.
The first phase of the programme managed to attract more than 600 applicants, with over 100 start-ups selected from the diagnostics, medical device and therapeutics fields.
“We hope to make use of Hong Kong’s advantages to attract mainland [Chinese] life and health tech start-ups, connect them internationally,” Chim said at the revamped scheme’s launch ceremony.
Advertisement
“In terms of quantity, I believe we can at least double the number of companies compared to the first programme.”